SSI Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
SSI Investment Management's BIIB Position: Q3 2021 in Review
SSI Investment Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 570 shares — an estimated $200K sold.
SSI Investment Management first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $552K in Q4 2014. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- SSI Investment Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
- SSI Investment Management sold 570 Biogen shares in Q3 2021, an estimated $200K.
- SSI Investment Management first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
- SSI Investment Management's Biogen position peaked at $552K in Q4 2014.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on SSI Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.